Tatyana Kushner, MD, MSCE: HCV Screening, Treatment, and Elimination

November 11, 2023                               HC P LIVE
Abigail Brooks, MA                               Conference|American Association for the Study of Liver Diseases                  

Tatyana Kushner, MD, MSCE, sat down with HCPLive to discuss the White House hepatitis C elimination plan.

In an interview with HCPLive during The Liver Meeting 2023 from the American Association for the Study of Liver Diseases (AASLD) in Boston this weekend, Tatyana Kushner, MD, MSCE, associate professor of medicine in the division of liver diseases at the Icahn School of Medicine at Mount Sinai, discussed the White House hepatitis C elimination plan, clinicians’ role in addressing this issue, and disparities in patients affected by HCV.
“The goal is to have a national plan to work towards hepatitis C elimination, and within that proposed plan, there are specific aspects to address,” Kushner explained.
Components of the goal include providing easier access to medications, improving the process from testing to treatment, and emphasizing the need for research, especially as it pertains to the development of a hepatitis C vaccine. Beyond those elements, Kushner also described the role clinicians must play in eliminating HCV and emphasized the need for screening.
“If you're seeing a patient, whether it's in primary care or any other healthcare setting, you need to screen them for hepatitis C. And that is really, really important. Even if you're not someone who sees many hepatitis C patients, it is an important part of your healthcare maintenance that you need to screen,” Kushner said

​TO CONTINUE: https://www.hcplive.com/view/tatyana-kushner-md-msce-hcv-screening-treatment-and-elimination